Able Move Chosen as Winner of Stelios Award for Disabled Entrepreneurs 2018
26 November 2018 / Posted in: Information, Support
Able Move, a start-up company that has created a portable solution for disabled travellers, has been chosen as winner of this award, in partnership with Leonard Cheshire. The company was founded by Josh Wintersgill, a cyber-security manager from Bristol, who has SMA.
Biogen wins UK Prix Galien award for nusinersen, but we are all still waiting for news from NICE
23 November 2018 / Posted in: Treatments & Research
On 15th November, Biogen was announced as the winner of the Orphan Product Award for Spinraza® (nusinersen). They comment, ‘we must see this translated into availability for the patients who desperately need it’. We agree and will keep working on this.
ORR Improving Assisted Travel Consultation
19 November 2018 / Posted in: Information, Support
A consultation being run by the Office of Rail and Road (ORR) sets out proposals to change the Disabled People's Protection Policy (DPPP) Guidance for train and station operators on how to write their policies for helping disabled people to travel by rail.
Rare Disease Day 2019 Theme Announced
19 November 2018 / Posted in: Treatments & Research
The theme for the day has been announced as ‘Bridging Health and Social Care’. The 12th edition of the campaign will focus on the need to bridge the gaps in the coordination between medical, social and support services for people affected by a rare disease.
SMA UK Busy Heading Out and About
13 November 2018 / Posted in: Treatments & Research
Last week, along with MDUK, we were patient reps at NICE’s scoping meeting for AVXS-101 for SMA Type 1. We also attended Genetic Alliance UK’s workshop for rare disease groups discussing a Patient Charter for Newborn Screening in the UK.
Latest NICE Community Update re Nusinersen
12 November 2018 / Posted in: Treatments & Research
This latest SMA Community update from NICE doesn't give a decision yet but states that talks are still progressing.
Universal Credit and Universal Support
01 November 2018 / Posted in: Information, Support
The charity Turn2Us have written an article explaining how people claiming Universal Credit can get help through Universal Support which enables them to make a claim and manage ongoing payments.
Biogen Statement to SMA Community re: EAP for SMA Type 1 in England, Wales and Northern Ireland
01 November 2018 / Posted in: Treatments & Research
Despite our urgent request, Biogen has not extended the cut off for this programme to 1st December. It ends now for any newly diagnosed infants. Read their community statement here.
Update on Access to Nusinersen
26 October 2018 / Posted in: Treatments & Research
Thank you to the patient and clinical experts who strongly advocated for access to nusinersen at NICE’s committee meeting this week; to clinicians, families and adults who: expressed their views in their submissions to NICE; wrote letters to MPs, NICE, NHS England and Biogen; were there on the day.
SMA UK Social Media Pages
25 October 2018 / Posted in: Help Us
As the merger has now taken place, we have updated our social media pages to 'SMA UK'. For anyone who was following The SMA Trust, please now make sure you are following SMA UK's pages.
